ѻý

<ѻý class="page-title">Clinical Challenges

ESMO: Breast Cancer HER2-

<ѻý class="page-description">

More in ESMO: Breast Cancer HER2-

Clinical Challenges: Sequencing in Second-Line Therapy in HR-positive Breast Cancer

Optimal therapy still varies by individual patient

Oct 18, 2019
A male physician discusses treatment options with a female breast cancer patient